Conditions: Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck; Carcinoma, Squamous Cell of Head and Neck
Interventions: Drug: Nivolumab and Ipilimumab; Drug: Docetaxel
Sponsors: AIO-Studien-gGmbH; Bristol-Myers Squibb
Recruiting
https://ift.tt/2Mvu6sd
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: Available online 22 March 2017 Source: Medical Journal Armed Forces India Author(s): S.C. Shaw, M.S. Vinod, Amit Devgan ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου